Merck & Co., Inc. (NYSE: MRK)

1 Merck Dr.
Whitehouse Station, NJ 08889-0100 (Map)
Phone: 908-423-1000
Fax: 908-735-1253
http://www.merck.com

Overview

The new Merck (formerly Schering-Plough) makes medicines for a number of ailments, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include asthma medication Singulair, anti-inflammatory Remicade, hypertension fighters Cozaar and Hyzaar, and cholesterol combatants Vytorin, Zetia, and Zocor. The company also makes animal health pharmaceuticals, as well as childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Its OTC drug and personal care offerings include Claritin allergy pills and Dr. Scholl's foot care products. The company completed a reverse merger with the old Merck in 2009 and took on the Merck name.

Sample Overview & History

Key Numbers from Hoover's UK

Key financials for Merck & Co., Inc. (NYSE: MRK)

Company Type Public (NYSE: MRK)
Fiscal Year-End December
2008 Sales (mil.) £12,777.5
1-Year Sales Growth 45.8%
2008 Net Income (mil.) £1,314.2
2008 Employees 51,000
1-Year Employee Growth (7.3%)
Get more Key Numbers
TIP: Understand how a company performs against its industry by reviewing Comparison Data. Column-to-column comparisons to the industry and the market are available with a Hoover's subscription.
TIP: Subscribers have access to detailed financial data (income statement, balance sheet, cash flow) for more than 500,000 public and private companies in the UK.

Key People from Hoover's UK

Key people and executives for Merck & Co., Inc. (NYSE: MRK)

Chairman, President, and CEO Richard T. (Dick) Clark
(Subscribers see complete biographies -- view sample)

Connect to this executive
EVP and CFO Peter N. Kellogg
Connect to this executive
Media Contact, Scientific Affairs, R&D, and Licensing and Partnerships Ian McConnell
Connect to this executive
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.

Top Competitors from Hoover's UK

Top competitors of Merck & Co., Inc. (NYSE: MRK)

There are 35 competitors for Merck; see more.
TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.

Significant Developments

View company events at Merck & Co., Inc. (NYSE: MRK) such as IPOs, bankruptcies, or executive changes

Event Details
Auditor Change Subscribers get full details --
view a sample
Auditor Change
Name Change
More Significant Developments

Industry Information from Hoover's UK

First Research Industry Profiles Extensive Industry Intelligence

Hoover's Industries

More Industry Information
TIP: Hoover's proprietary industry structure allows you to tell at-a-glance how diversified a company's operations are, and which line of business can be considered a company's primary industry.

Subsidiaries/Affiliates Covered By Hoover's UK

Subsidiaries/affiliates of Merck & Co., Inc. (NYSE: MRK)

TIP: Use subsidiary and affiliate information to determine easy cross-sell and upsell opportunities within an organization or business line. Hoover's subscribers have full access to detailed Family Tree information.

Rankings from Hoover's UK

See how Merck & Co., Inc. (NYSE: MRK) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones

  • #138 in FORTUNE 500
  • S&P 500
  • #103 in FT Global 500
TIP: Hoover's subscribers have access to FT 500 and other rankings that make targeted list building easy.

Subscribers Get More!

Search Hoover's UK

View Hoover's UK Free Content

Buy A Report on Merck:

Sample UK Subscriber Content


Bizmology

No Christmas wrapping on toy safety reforms

by Linnea Kirgan, Jan. 2nd, 2008
Read more at Bizmology.com.


Companies That Exceed Expectations

Who's going above and beyond the status quo? Learn more about these groundbreaking companies!

Current Edition: Click Here



Small Business Expert

Presented by Comcast Business Class

Read More from the Current Edition: Performance Reviews



Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy